HomeMedical SpecialtiesRehabilitationRehabilitation technology helping patients

Rehabilitation technology helping patients

Published on

By Shelly Willsey

When Hussain Alhussainy puts on a high-tech exoskeleton during therapy, he feels like Iron Man.

Earlier this year, the 16-year old became one of Glenrose Rehabilitation Hospital’s first pediatric patients to use the Ekso GT exoskeleton as part of his therapy for cerebral palsy.

The Glenrose is finding new ways to use this wearable robot that lets a person with lower extremity weakness stand up and walk. The Ekso was first introduced to Glenrose adult patients in 2015, but new features have since led to new therapies for adult patients as well as the opportunity to help pediatric patients.

“Not only does it allow me to walk, but it helps with my posture and guides me on how to walk,” says the Edmonton teen. “It makes you put in the work for your therapy, and if you can’t, it assists you. It makes me feel powerful.”

The Ekso measures the wearer’s shifts in balance, weight and posture, and motors in the suit’s knees and hips auto-adjust to deliver the right amount of power that’s needed to walk.

The technology even offers new features that now allow therapists to isolate a specific leg, lessen the amount of assistance the suit provides or increase the resistance.

“As our Glenrose team becomes further trained with the Ekso and the programming advances, we’re able to expand the kinds of patients we’re helping,” says Vickie Buttar, the hospital’s Rehabilitation Technology Leader, Physical Therapy.

“We use it with patients who are relearning to walk and, with new features, we have broader applications. We can use it to strengthen patients’ legs, improve balance and increase endurance.”

When the Ekso was introduced to the hospital three years ago, it was used in early mobilization for adult patients with stroke, and spinal or brain injuries.

To date, more than 80 patients at the Glenrose have used the Ekso during their rehabilitation.

Ryan Nicoll, 31, was using the Ekso as part of his rehabilitation from a spinal cord injury when the new features were introduced. Therapists were able to extend his Ekso therapy and increase his strength and endurance.

“I feel like my therapy is further along thanks to the Ekso,” says the resident of Mannville, 170 km east of Edmonton.

“When I started therapy, I was walking a little bit but I’m walking almost full-time now. The Ekso is a great tool that has helped me tremendously.”

Shelly Willsey is a Senior Communications Advisor at Alberta Health Services.

 

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

Martha Tripicio – Nursing Hero

Humber River Health t is with profound respect and admiration that I nominate Martha Tripicio...

Catherine Bergman – Nursing Hero

University Health Network Catherine Bergman is recognized at Toronto General Hospital for her clinical expertise,...

Iryna Fedoryak – Nursing Hero

Sunnybrook Health Sciences Centre (St. John’s Rehab) We are honoured to nominate Iryna Fedoryak for...

Domino Puson – Nursing Hero

Trillium Health Partners We are honoured to nominate Domino Puson for the 21st Annual Hospital...

Susan Davidson 3rd Place Nursing Hero

Unity Health (St. Joseph’s Health Centre) am honored to nominate Susan Davidson for the Nursing...

Rodolfo D. Lastimosa Jr. 2nd Place Nursing Hero

Southbridge Care Homes am honored to nominate Rodolfo D. Lastimosa Jr. for the Nursing Hero...